LOADING
Comparing NVIDIA Corporation (NVDA) and Eli Lilly and Company (LLY) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | LLY |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $4.86T | $1.03T |
| P/E Ratio | 30.8 | 40.8 |
| Forward P/E | 22.9 | 33.9 |
| PEG Ratio | 0.55 | 1.61 |
| EPS | $6.52 | $28.15 |
| Revenue Growth (YoY) | 85.2% | 55.5% |
| Profit Margin | 63.0% | 35.0% |
| Return on Equity | 114.3% | 107.5% |
| Dividend Yield | 0.02% | 0.54% |
| Beta | 2.21 | 0.51 |
| 52-Week High | $236.26 | $1,249.45 |
| 52-Week Low | $163.85 | $619.40 |
| Volume | -- | -- |
NVIDIA Corporation is the larger company by market capitalization. NVIDIA Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Eli Lilly and Company offers a higher dividend yield for income investors. NVIDIA Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.